skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α

Abstract

Gallbladder cancer (GBC) is an aggressive malignancy of the bile duct, which is associated with a low (5-year) survival and poor prognosis. The transcription factor HIF-1α is implicated in the angiogenesis, cell survival, epithelial mesenchymal transition (EMT) and invasiveness of GBC. In this study, we have investigated the role of HIF-1α in the pathobilogy of GBC and effect of hispidulin on the molecular events controlled by this transcription factor. We observed that hispidulin caused induction of apoptosis, blockade of growth and cell cycle progression in GBC cells. Our results have demonstrated for the first time that hispidulin-exerted anti-tumor effect involved the suppression of HIF-1α signaling. Hispidulin was found to repress the expression of HIF-1α protein dose-dependently without affecting the HIF-1α mRNA expression. In addition, the inhibition of HIF-1α protein synthesis was revealed to be mediated through the activation of AMPK signaling. Hispidulin also sensitized the tumor cells to Gemcitabine and 5-Fluoroucil by down-regulating HIF-1α/P-gp signaling. Given the low cost and exceedingly safe profile, hispidulin appears to be a promising and novel chemosensitizer for GBC treatment. - Highlights: • Hispidulin inhibits proliferation of gallbladder cancer cells by targeting HIF-1α. • Hispidulin regulates HIF-1α via activating AMPK signaling. • Hispidulin sensitized themore » GBC cells to chemotherapeutics by down-regulating P-gp.« less

Authors:
;  [1];  [2];  [1]; ; ;  [1]
  1. Medical College, Qingdao University, Qingdao, Shandong 266071 (China)
  2. College of Life Sciences, Chongqing Normal University, Chongqing 401331 (China)
Publication Date:
OSTI Identifier:
22462272
Resource Type:
Journal Article
Resource Relation:
Journal Name: Experimental Cell Research; Journal Volume: 332; Journal Issue: 2; Other Information: Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; ANGIOGENESIS; APOPTOSIS; BILIARY TRACT; CELL CYCLE; DOSES; INHIBITION; MESSENGER-RNA; NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR CELLS

Citation Formats

Gao, Hui, Xie, Jing, Peng, Jianjun, E-mail: jianjunpeng@126.com, Han, Yantao, E-mail: hanyt19@126.com, Jiang, Qixiao, Han, Mei, and Wang, Chunbo. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α. United States: N. p., 2015. Web. doi:10.1016/J.YEXCR.2014.11.021.
Gao, Hui, Xie, Jing, Peng, Jianjun, E-mail: jianjunpeng@126.com, Han, Yantao, E-mail: hanyt19@126.com, Jiang, Qixiao, Han, Mei, & Wang, Chunbo. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α. United States. doi:10.1016/J.YEXCR.2014.11.021.
Gao, Hui, Xie, Jing, Peng, Jianjun, E-mail: jianjunpeng@126.com, Han, Yantao, E-mail: hanyt19@126.com, Jiang, Qixiao, Han, Mei, and Wang, Chunbo. Sun . "Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α". United States. doi:10.1016/J.YEXCR.2014.11.021.
@article{osti_22462272,
title = {Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α},
author = {Gao, Hui and Xie, Jing and Peng, Jianjun, E-mail: jianjunpeng@126.com and Han, Yantao, E-mail: hanyt19@126.com and Jiang, Qixiao and Han, Mei and Wang, Chunbo},
abstractNote = {Gallbladder cancer (GBC) is an aggressive malignancy of the bile duct, which is associated with a low (5-year) survival and poor prognosis. The transcription factor HIF-1α is implicated in the angiogenesis, cell survival, epithelial mesenchymal transition (EMT) and invasiveness of GBC. In this study, we have investigated the role of HIF-1α in the pathobilogy of GBC and effect of hispidulin on the molecular events controlled by this transcription factor. We observed that hispidulin caused induction of apoptosis, blockade of growth and cell cycle progression in GBC cells. Our results have demonstrated for the first time that hispidulin-exerted anti-tumor effect involved the suppression of HIF-1α signaling. Hispidulin was found to repress the expression of HIF-1α protein dose-dependently without affecting the HIF-1α mRNA expression. In addition, the inhibition of HIF-1α protein synthesis was revealed to be mediated through the activation of AMPK signaling. Hispidulin also sensitized the tumor cells to Gemcitabine and 5-Fluoroucil by down-regulating HIF-1α/P-gp signaling. Given the low cost and exceedingly safe profile, hispidulin appears to be a promising and novel chemosensitizer for GBC treatment. - Highlights: • Hispidulin inhibits proliferation of gallbladder cancer cells by targeting HIF-1α. • Hispidulin regulates HIF-1α via activating AMPK signaling. • Hispidulin sensitized the GBC cells to chemotherapeutics by down-regulating P-gp.},
doi = {10.1016/J.YEXCR.2014.11.021},
journal = {Experimental Cell Research},
number = 2,
volume = 332,
place = {United States},
year = {Sun Mar 15 00:00:00 EDT 2015},
month = {Sun Mar 15 00:00:00 EDT 2015}
}